A BEACON OF HOPE: NEW ADJUVANT TREATMENT OPTIONS FOR PANCREATIC ADENOCARCINOMA

Authors

  • Catarina Mendes Oncologia Médica, IPO Porto, Porto, Portugal
  • Miguel Silva Oncologia Médica, Centro Hospitalar Lisboa Ocidental (CHLO), Lisboa, Portugal
  • Mário Fontes e Sousa Oncologia Médica, Centro Hospitalar Lisboa Ocidental (CHLO), Lisboa, Portugal
  • Inês Duarte Oncologia Médica, Unidade Local de Saúde de Matosinhos, Hospital Pedro Hispano, Matosinhos, Portugal

Keywords:

Pancreatic Adenocarcinoma, Adjuvant Chemotherapy, Positive Clinical Trials

Abstract

Pancreatic adenocarcinoma is currently a major public health problem, being the 7th cause of death worldwide. Incidence is increasing and unfortunately nowadays the incidence is almost overlapping to mortality. The cornerstone of curative treatment is still surgery, but adjuvant treatment is critical to decreasing the risk of recurrence.

Downloads

Published

2024-06-05

Issue

Section

Articles